Nirsevimab Uptake in a Pediatric Primary Care Network During the 2023-2024 RSV Season

Authors:

Abstract
This cohort study characterizes nirsevimab uptake among infants who did and did not receive the respiratory syncytial virus (RSV) vaccine during the 2023 to 2024 RSV season.